GRRO China

The China Subgroup proactively develops collaborative relationships with various stakeholders in China, including Chinese FDA and provincial FDAs, pharmacopeia, other standard-setting bodies, pharmaceutical industry, suppliers and other trade groups.  The Subgroup stays abreast of, and influences as appropriate, regulatory developments for OINDPs in China. 

The China Subgroup has been actively reaching out to Chinese FDA (CFDA) with the goal to help shape the development of scientifically-based guidances and regulations for OINDP in China.  Through its effort, IPAC-RS is now recognized by the CFDA as a leading resource for scientific knowledge and expertise in OINDP industry.

The China Subgroup is also liaising with other industry or trade associations, especially those China-located associations, to monitor and influence the development of best practices, standards and regulations for OINDPs.  These associations include R&D-based Pharmaceutical Association Committee in China (RDPAC) and Inhalation Drug Delivery Association (IDDA) in China.

Through material translation (e.g. translation of IPAC-RS webinars on Materials Quality, L&E Handbook), conference presentations and webinar/workshop sponsorship, the Subgroup is helping, and will continue to help, educate stakeholders in China on OINDPs.


GRRO China and Materials Working Groups - July 2016

The GRRO China and Materials Working Groups are leading the consolidation and submission of IPAC-RS comments on the CNPPA guideline for elastomeric components for drug products (including inhalation products).

GRRO China Update (October 2015)

On 8 September, GRRO China representatives met with NIFDC leaders in Beijing, China and traveled to Shenyang, China to attend Inhalation Asia 2015.

GRRO China Update - September 2015

IPAC-RS representatives were invited to and will participate in a symposium about the fundamentals of aerosols drugs organized by the National Institute for Food and Drug Control (NIFDC), a component of the Chinese FDA, and will chair and present at a session on materials quality and extractables/leachables at Inhalation Asia.

IPAC-RS Presentations in Taiwan and China

IPAC-RS representatives participated in a training workshop at the Taiwan Center for Drug Evaluation in September 2014. Their presentations were successful and very well received. They also participated in the Chinese National Pharmaceutical Packaging Association’s (CNPPA) 2014 Forum for Infusion Packaging Development on 18-19 September in Qingdao, China.

IPAC-RS RDD 2014 Presentations

At RDD 2014 in Puerto Rico, four IPAC-RS members representing GRRO China, the Device Working Group, and the Cascade Impaction Working Group gave very well-received presentations.

IPAC-RS Visit to China

IPAC-RS representatives met with representatives from the China National Pharmaceutical Packaging Association (CNPPA) to discuss the CNPPA translating the L&E Handbook into Chinese. During this meeting IPAC-RS participants presented general education information on L&E for inhalation products to a diverse audience of industry and regulatory attendees. IPAC-RS also met with the National Institutes for Food and Drug Control (NIFDC). NIFDC is keen to leverage IPAC-RS’ expertise and is interested in collaboration to include other types of drug product studies.

See member benefits

Become an IPAC-RS member today Participation in IPAC-RS affords a variety of benefits including opportunities to shape the scientific and regulatory environment and tools to stay informed.

Sign Up

IPAC-RS members can sign up to receive our monthly update on IPAC-RS and regulatory developments.